Liposomal doxorubicin: all 237 studies that test it
Page 3 of 3. Open to participants first (21), then studies with results posted, then the rest; newest registration first within each.
- END-1: First Line Chemotherapy for Advanced or Recurrent Endometrial Carcinoma With Carboplatin and Liposomal DoxorubicinCompletedNCT00401635Phase 2
- A Dose Study of Doxil in a Dose Dense, 14 Day CDOP/Rituximab Regimen for Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma (NHL)> 60 Years or With Compromised Cardiac Status.Status unknownNCT00333008Phase 2
- MITO-2: A Study Comparing 2 Chemotherapy Regimens (Carboplatin/Liposomal Doxorubicin vs Carboplatin/Paclitaxel) in Patients With Ovarian CancerStatus unknownNCT00326456Phase 3
- Lapatinib and Doxorubicin Hydrochloride Liposome in Treating Patients With Metastatic Breast CancerCompletedNCT00316875Phase 1
- Liposomal Doxorubicin Compared With Observation or Cyclophosphamide and Methotrexate in Treating Older Women Who Have Undergone Surgery for Breast CancerTerminatedNCT00296010Phase 3
- Caelyx Adjuvant in Elderly Breast CancerCompletedNCT00284336Phase 2
- DOXIL for Consolidation Therapy in Ovarian Cancer.CompletedNCT00248248Phase 2
- Liposomal Doxorubicin, Vincristine, & Dexamethasone Plus Arsenic Trioxide in Untreated Symptomatic Multiple MyelomaCompletedNCT00201695Phase 2
- Caelyx Plus Carboplatin Versus Paclitaxel Plus Carboplatin in Patients With Epithelial Ovarian Cancer in Late RelapseCompletedNCT00189553Phase 3
- Combination Chemotherapy Consisting of Pegylated Liposomal Doxorubicin and Carboplatin in Malignant Gynecologic TumoursCompletedNCT00189410Phase 2
- Pegylated Liposomal Doxorubicin (Doxil) With Rituximab in Relapsed AIDS-Related Non-Hodgkin's LymphomasTerminatedNCT00183976Phase 2
- Trial of Liposomal Doxorubicin (Doxil) and Weekly Docetaxel (Taxotere)CompletedNCT00183742Phase 1
- Phase I/II Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile of Lenalidomide (Revlimid® CC-5013) With Liposomal Doxorubicin In Subjects With Advanced Ovarian and Primary Peritoneal CarcinomaTerminatedNCT00179725Phase 1/2
- LAMPP Trial for Peripheral and Cutaneous T-Cell LymphomaTerminatedNCT00161239Not applicable
- A Trial of Doxil and Multiday Vinorelbine in Patients With Metastatic Breast CancerStatus unknownNCT00159094Phase 2
- Study of Combination Therapy With VELCADE, Doxil, and Dexamethasone (VDd) in Multiple MyelomaCompletedNCT00135187Not applicable
- Liposomal Doxorubicin and Estramustine Phosphate: Study in Taxane Resistant, Hormone Refractory Advanced Prostate CancerTerminatedNCT00132756Phase 1/2
- Maintenance Treatment With Liposomal Doxorubicin (Caelyx) in Metastatic Breast Cancer PatientsCompletedNCT00128778Phase 4
- Velcade, Doxil, and Dexamethasone (VDd) as First Line Therapy for Multiple MyelomaCompletedNCT00116961Phase 2
- Study of Doxil in the Treatment of Patients With Refractory Idiopathic Thrombocytopenic PurpuraStatus unknownNCT00107913Phase 2
- Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease ActivityActive, not recruitingNCT00092222Phase 2
- Bortezomib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Previously Untreated Symptomatic Multiple MyelomaCompletedNCT00088855Phase 2
- To Compare Treatment With Doxorubicin or Capecitabine for Metastatic Breast Cancer in Women 60 Years and OlderTerminatedNCT00082095Phase 3
- Liposomal Doxorubicin in Treating Patients With Stage IIB, Stage IVA, or Stage IVB Recurrent or Refractory Mycosis FungoidesCompletedNCT00074087Phase 2
- Liposomal Doxorubicin and Thermal Therapy in Treating Patients With Prostate CancerCompletedNCT00061867Phase 1
- Liposomal Doxorubicin in Treating Patients With Persistent or Recurrent Cancer of the CervixTerminatedNCT00030472Phase 2
- Liposomal Doxorubicin in Treating Children With Refractory Solid TumorsCompletedNCT00019630Phase 1
- Phase I/II Trial of Doxil and Hyperthermia for Breast Cancer Patients With Chest Wall Recurrence or Stage IV Disease With Locally Advanced Breast CancerStatus unknownNCT00006433Phase 2
- Combination Chemotherapy in Treating Patients With Advanced Solid TumorsCompletedNCT00006372Phase 1
- Comparison of Two Regimens of Liposomal Doxorubicin in Treating Women With Metastatic Breast CancerCompletedNCT00005980Phase 2
- Liposomal Doxorubicin in Treating Patients With Advanced or Recurrent Endometrial CancerCompletedNCT00005861Phase 2
- Chemotherapy in Treating Patients With Sarcoma of the UterusCompletedNCT00005643Phase 2
- Liposomal Doxorubicin in Treating Patients With Advanced Stomach CancerStatus unknownNCT00004236Phase 2
- Liposomal Doxorubicin Plus Combination Chemotherapy in Treating Patients With AIDS-Associated Non-Hodgkin's LymphomaCompletedNCT00004162Phase 1
- Liposomal Doxorubicin in Treating Patients With Prostate CancerCompletedNCT00004014Phase 2
- Paclitaxel Compared With Doxorubicin in Treating Patients With Advanced AIDS-Related Kaposi's SarcomaCompletedNCT00003350Phase 3
- Liposomal Doxorubicin and PSC 833 in Treating Patients With AIDS-Related Kaposi's Sarcoma or Other Advanced CancersCompletedNCT00003207Phase 1